Listed

Reflect Scientific, Inc.: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 12, 2013 and accepted by EDGAR at Nov 12, 2013, 16:24 ET.

Share

Management's discussion and analysis

As filed, 13,263 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Special Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of our Company. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Annual Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward- looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest; changes in U.S., global or regional economic conditions, changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments; increased competitive pressures, both domestically and internationally, legal and regulatory developments, such as regulatory actions affecting environmental activities, the imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls; adverse weather conditions or natural disasters, such as hurricanes and earthquakes, labor disputes, which may lead to increased costs or disruption of operations.

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited Financial Statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three and nine month periods ended September 30, 2013, to the items disclosed as significant accounting policies in management's Notes to the Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2012.

Plan of Operation and Business Growth

Our efforts continue focus on increasing the sales of our life science consumables and detectors while, at the same time, working on the commercialization of our liquid nitrogen refrigeration products. Of those liquid nitrogen refrigeration products, the refrigerated trailer, known as a “reefer”, is receiving highest priority. We have our first manufactured unit operational and are currently conducting road tests and collecting data as to its efficiency and reliability.

We also continue to focus on the expansion of our detector line and developing alliances with contract manufacturers for our ultra-low temperature freezers and reefer units. Our new detector unit has received very positive reviews. We believe that its enhanced functionality, coupled with its low cost, will provide us with a competitive edge over products currently being sold in that specialized market.

Concurrent with the development and commercialization of the above products, we have completed our on-line catalog and are making progress in enrolling new distributors for our consumable products. We believe the upturn in sales during the three months ended September 30, 2013 is validation of those efforts.

Our revenues during the reporting period increased more than 27% during 2013 compared to 2012 revenues. We attribute this increase in revenue to the concerted effort made in developing and publishing our new catalog, developing and implementing our new web site, and the adding of new distributors. While one quarter does not establish a trend, we are encouraged by the results to date. We are working to bring on additional distributors who will carry our entire line of specialty laboratory products, expanding our markets and leveraging their existing customer bases. While some of our products are relatively new to the marketplace and we expect the demand for those to grow as customers become more familiar them, there are a number of our product lines which are well established and have strong, consistent demand. With the addition of new distribution channels we believe that sales will increase over the remainder of the year.

Results of Operations

Three Months Ended September 30, 2013 and 2012

For the three months ended September 30, 2013 2012 Change
Revenues $389,562 $305,713 $83,849
Cost of goods sold 181,931 145,822 36,109
Gross profit 207,631 159,891 47,740
Operating expenses 222,621 278,668 (56,047)
Other income (expense) (30,459) 3,404,523 (3,434,982)
Net income (loss) $(45,449) $3,285,746 $(3,331,195)

Revenues increased during the quarter ended September 30, 2013, to $389,562 from $305,713 for the quarter ended September 30, 2012, an increase of $83,849. We completed our catalog web site and have distributed our catalog to a number of potential new distributors. We believe the upward trend of revenues seen during the quarter result from those efforts. We have added additional distributors to expand the distribution channels for our products. All of the revenues generated during the three month period ended September 30, 2013 were from our specialized laboratory supplies and detector sales. We are continuing work to refine and commercialize the ultra low temperature freezer technologies, and have hired a consulting group to identify and qualify potential customers for those technology products.

With increased sales during the reporting period, cost of goods increased in the quarter ending September 30, 2013, as compared to September 30, 2012 to $181,931 from $145,822, an increase of $36,109. The gross profit percentage increased to 53% for the three months ended September 30, 2013, compared to 52% for the three months ended September 30, 2012. The gross profit percentage is dependent on the mix of product sales, which varies from quarter to quarter, and was benefited in the current quarter by an increase in detector sales, which carry higher margins than our commodity products. We continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on our product lines.

As a result of our continued focus on operating expenses we realized a reduction of operating expenses in the current period. This reduction is the result of cost reduction efforts implemented by management and an ongoing quest to gain additional operating efficiencies. Operating expenses for the three months ended September 30, 2013 were $222,621, which represents a decrease of $56,047 from the $278,668 in operating expenses recorded for the three month period ended September 30, 2012. The decrease results primarily from reductions in professional fees, research and development expenses and lower depreciation and amortization charges, offset in part by increases in consulting fees and advertising costs. Operating expenses for the remaining three months of 2013 are expected to approximate the expense levels shown for the three month period ended September 30, 2013.

The net loss for the three month period ended September 30, 2013 was $45,449, a decrease of $3,331,195 from the $3,285,746 profit for the three month period ended September 30, 2012, which benefited from the $3,428,875 gain on extinguishment of debt. Management continues to look for opportunities to increase sales, improve gross margins and reduce ongoing operating expenses in order to achieve sustained profitability.

The net loss for the three months ended September 30, 2013 was $0.01 per share. The net profit for the three months ended September 30, 2012 was also $0.07 per share.

Nine Months Ended September 30, 2013 and 2012

For the nine months ended September 30, 2013 2012 Change
Revenues $954,527 $988,427 $(33,900)
Cost of goods sold 448,923 481,811 (32,888)
Gross profit 505,604 506,616 (1,012)
Operating expenses 665,940 831,071 (165,131)
Other income (expense) (83,940) 3,137,902 (3,221,842)
Net loss $(244,276) $2,813,447 $(3,057,723)

Revenues decreased during the nine month period ended September 30, 2013, to $954,527 from $988,427 for the nine month period ended September 30, 2012, a decrease of $33,900. All of the revenues were generated from our specialized laboratory supplies and detector sales, as we work to continue to refine and commercialize the ultra low temperature freezer technologies. We completed our catalog web site and have distributed our catalog to a number of potential new distributors. We have brought on additional distributors to expand the distribution channels for our products.

Decreased sales during the reporting period reduced cost of goods in the nine month period ending September 30, 2013 by $32,888, to $448,923 for the nine month period ended September 30, 2013 from $481,811 for the nine month period ended September 30, 2012. The gross profit percentage increased to 53% for the nine month period ended September 30, 2013, compared to 51% for the nine months ended September 30, 2012. The gross profit percentage is dependent on the mix of product sales, which varies from quarter to quarter. We continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on our product lines.

Continued focus to reduce operating expenses resulted in a reduction of $165,131 in the current nine month period. This reduction is the result of cost reduction efforts implemented by management and an ongoing quest to gain additional operating efficiencies. Operating expenses for the nine months ended September 30, 2012 were $831,071, compared to $665,940 shown for the nine month period ended September 30, 2013.

The net loss for the nine month period ended September 30, 2013 was $244,276, a $3,057,723 decline from the $2,813,447 net income for the nine month period ended September 30, 2012, which benefited from the $3,428,875 gain on extinguishment of debt. Management continues to look for opportunities to increase revenue, improve gross margins and reduce ongoing operating expenses in order to achieve profitability.

The net loss for the nine months ended September 30, 2013 was $0.01 per share. The net profit for the nine months ended September 30, 2012 was $0.06 per share.

Seasonality and Cyclicality

We do not believe our business is cyclical.

Liquidity and Capital Resources

Our cash resources at September 30, 2013, were $191,385, with accounts receivable of $168,328 and inventory of $329,267. To this time we have relied on revenues and sales of equity and debt securities for our cash resources. Our working capital deficit on September 30, 2013, was $623,284, due primarily to the $650,000 in outstanding debentures and $500,625 in accrued interest on those debentures. Working capital on December 31, 2012 was a deficit of $414,835. Management is working to obtain financing to enable it to retire the remaining outstanding debentures and provide the capital needed to commercialize the low temperature freezer and refrigeration technology. There can be no assurance that funds will be available, or that terms of available funds will be acceptable to the Company. The inability of the Company to obtain funding at acceptable terms could negatively impact its ability to execute its business plan.

For the nine month period ended September 30, 2013, net cash used for operating activities was $66,403 which compares to $125,025 of net cash used for operating activities for the nine month period ended September 30, 2012.

Off-Balance Sheet Arrangements

We lease office and warehouse space under a non-cancelable operating lease in Utah. Future minimum lease payments under the operating lease at September 30, 2013 are $43,400 for that facility. In addition, we have automobile leases with future minimum lease payments of $3,930.

Market risk

As filed, 454 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

At September 30, 2013, the remaining outstanding convertible debentures in default were $650,000, including penalties. The debentures bear an 18% interest rate. The Company accrued an additional $29,250 in interest during the quarter ended September 30, 2013. The total accrued interest on this remaining debenture was $500,625 as of September 30, 2013. Assuming the debentures were converted, 1,000,000 shares of restricted common stock would be issued.

Controls and procedures

As filed, 1,670 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a)

Evaluation of Disclosure Controls and Procedures.

As of the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management, including our Chief Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures are effective to a reasonable assurance level of achieving such objectives. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

(b)

Changes in Internal Control Over Financial Reporting.

There were no changes in our internal control over financial reporting during the period covered by this Quarterly Report.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$389.6kus-gaap:Revenues
Revenue9 months2013-01-01 to 2013-09-30$954.5kus-gaap:Revenues
Cost of revenue3 months2013-07-01 to 2013-09-30$181.9kus-gaap:CostOfGoodsSold
Cost of revenue9 months2013-01-01 to 2013-09-30$448.9kus-gaap:CostOfGoodsSold
Gross profit3 months2013-07-01 to 2013-09-30$207.6kus-gaap:GrossProfit
Gross profit9 months2013-01-01 to 2013-09-30$505.6kus-gaap:GrossProfit
Research and development3 months2013-07-01 to 2013-09-30$12.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-01-01 to 2013-09-30$29.2kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-07-01 to 2013-09-30−$15.0kus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30−$160.3kus-gaap:OperatingIncomeLoss
Interest expense3 months2013-07-01 to 2013-09-30−$1.9kus-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30−$5.8kus-gaap:InterestExpense
Income tax3 months2013-07-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-07-01 to 2013-09-30−$45.4kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30−$244.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Cash and equivalentsAt period end2013-09-30$191.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$710.7kus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$1.1mus-gaap:Assets
Current liabilitiesAt period end2013-09-30$1.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-09-30$1.3mus-gaap:Liabilities
Shareholders' equityAt period end2013-09-30−$208.1kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001548123-13-000422. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.